Briacell Therapeutics Corp. Common Shares
Symbol: BCTX (NASDAQ)
3.60
▲ (1.27%) 0.045
Company Description:
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.
Key Stats
- Today's Open: $3.635
- Today's High: $3.635
- Today's Low: $3.595
- Today's Volume: 180
- Yesterday Close: $3.55
- Yesterday High: $3.72
- Yesterday Low: $3.44
- Yesterday Volume: 195.35K
- Last Min Volume: 1
- Last Min High: $3.595
- Last Min Low: $3.595
- Last Min VWAP: $3.595
Company Profile
- Name: Briacell Therapeutics Corp. Common Shares
- Website: https://www.briacell.com
- Listed Date: 2023-09-05
- Location: WEST VANCOUVER, A1
- Market Status: Active
- CIK Number: 0001610820
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $20.33M
- Round Lot: 100
- Outstanding Shares: 6.78M
- Asset Type: CS
RECENT FILINGS FOR BCTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-05-13 | SCHEDULE 13G/A | View |
| 2025-05-01 | SCHEDULE 13G | View |
| 2025-04-28 | 8-K | View |
| 2025-04-28 | 424B4 | View |
| 2025-04-28 | 424B4 | View |
| 2025-04-24 | EFFECT | View |
| 2025-04-24 | S-1MEF | View |
| 2025-04-24 | CERT | View |
| 2025-04-24 | 8-A12B | View |
| 2025-04-23 | S-1/A | View |
| 2025-04-22 | FWP | View |
| 2025-04-22 | S-1 | View |
| 2025-03-12 | DRS | View |
| 2025-03-12 | 10-Q | View |
| 2025-03-12 | 8-K | View |
| 2025-02-13 | 8-K | View |
| 2025-02-10 | SCHEDULE 13G | View |
| 2025-02-06 | 8-K | View |
| 2025-02-05 | 8-K | View |
| 2025-02-04 | 424B5 | View |
Latest News on BCTX